XM does not provide services to residents of the United States of America.
A
A

AutomaticData

News

ADP Increases Cash Dividend Marks 50Th Consecutive Year Of Dividend Increases

BRIEF-ADP Increases Cash Dividend Marks 50Th Consecutive Year Of Dividend Increases Nov 6 (Reuters) - Automatic Data Processing Inc ADP.O : ADP INCREASES CASH DIVIDEND; MARKS 50TH CONSECUTIVE YEAR OF DIVIDEND INCREASES AUTOMATIC DATA PROCESSING INC - APPROVES $0.14 INCREASE IN QUARTERLY CASH DIVIDEND Source text: ID:nPn6Y1wza Further company covera
A

U.S. Amazon, Chevron, Mastercard

U.S. RESEARCH ROUNDUP-Amazon, Chevron, Mastercard Nov 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amazon, Chevron and Mastercard, on Monday. HIGHLIGHTS * Amazon AMZN.O : Raymond James raises target price to $230 from $205 * Chevron Corp CVX.N : Raymond James raises target price to $175 from $170 * Mastercard MA.N : Macquarie raises target price to $565 from $505 * Vertex Inc VERX.O : Jefferies raises to buy fro
A
A
A
B
C
C
D
E
G
M
S
A
T
W
B
C
R
T

U.S. Amazon, IQVIA Holdings, Uber

U.S. RESEARCH ROUNDUP-Amazon, IQVIA Holdings, Uber Nov 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amazon, IQVIA Holdings and Uber, on Friday. HIGHLIGHTS * Amazon AMZN.O : JP Morgan raises target price to $250 from $230 * Cheniere Energy Inc LNG.N : Raymond James raises target price to $225 from $210 * IQVIA Holdings Inc IQV.N : TD Cowen cuts target price to $255 from $270 * Regeneron Pharmaceuticals Inc REGN.O
A
A
C
E
I
K
R
A
A
E
G
U
A
A
A
I

U.S. Amazon, IQVIA Holdings, Uber

U.S. RESEARCH ROUNDUP-Amazon, IQVIA Holdings, Uber Nov 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amazon, IQVIA Holdings and Uber, on Friday. HIGHLIGHTS * Amazon AMZN.O : JP Morgan raises target price to $250 from $230 * Cheniere Energy Inc LNG.N : Raymond James raises target price to $225 from $210 * IQVIA Holdings Inc IQV.N : TD Cowen cuts target price to $255 from $270 * Regeneron Pharmaceuticals Inc REGN.O
A
C
E
I
K
R
U
A
A
S
E
G
U
I

Paycom eyes record gain after Q3 results beat, multiple Wall Street PT hikes

BUZZ-Paycom eyes record gain after Q3 results beat, multiple Wall Street PT hikes ** Paycom Software's PAYC.N stock up 23.1% at $212 and easily top S&P 500 .SPX performer on Thurs as Wall Street analysts scurry to raise their price targets after qtrly results beat expectations ** Stock on course for biggest one-day pct gain on record ** Payroll processor late Weds reported Q3 rev of $452 mln, above LSEG estimate of $447 mln ** Adj EPS in qtr of $1.67 exceeds consensus by 6 cents ** Paycom has se
J
A
U
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.